The role of an in-house audit group as an innovative tool to review clinical trials

Trivedi, Shivali; Hathi, Krishna; Aslam, Natasha; Saleem, Nausheen; Gyertson, Kylie; Whelan, Jeremy

doi:10.1186/1745-6215-16-s2-o50

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…5,12 At the same time, through their collaboration with different sponsors and projects, clinical trial sites are expected to be well positioned to implement systematic risk management strategies. 13,14 Apart from the advantages to the clinical trial itself and the patients involved, the implementation of a risk management culture by sites can also help them to drive their own performance, strengthening decision-making process, and promoting the more sustainable and efficient use of their resources. 15 Over the last decade several attempts have been made in the UK to demonstrate the usefulness of risk management techniques in healthcare units, mainly to improve patient safety in current medical procedures.…”

Section: Introductionmentioning

confidence: 99%

Risk Management in Clinical Trials: Assessment of Current Practices at Portuguese Clinical Trial Sites

Vale,

Leite,

Madeira

2023

RMHP

View full text Add to dashboard Cite

Purpose Over the last years, in response to the increasing complexity and demand of clinical trials, there has been a growing concern with the application of efficient risk management methodologies. The main objective of this work is to assess the current level of implementation of risk management activities by clinical trials sites’ teams and identify points of improvement. Methods A cross-sectional study was conducted through an original, non-validated questionnaire created to assess the risk management practices at Portuguese clinical trial sites. The web-based survey was sent by e-mail to the clinical trial sites identified, and it was available for one month. Descriptive statistics were used to summarize the findings. Results In total, 46 clinical trial sites accepted to participate in this study. The surveys’ answers showed that although 57.0% of sites reported the use of a systematic risk management tool, only nine sites (19.6%) described a standard tool or document that captured systematically the analysis of risks at the site level. Most of the sites (87.0%) showed willing to use a risk management tool specifically tailored for their operational needs, with the lack of knowledge about risk management being the main reason against its implementation. Conclusion This work indicates that the surveyed clinical trial sites generally recognize the importance of risk management methodologies as an opportunity to anticipate difficulties in the trial conduct and optimize the use of sites’ resources. However, mainly due to lack of experience with risk management methodologies, sites are not currently implementing these strategies in the management of their trial-related operations. The development of a risk management tool for sites can be useful in this context.

show abstract

Section: Introductionmentioning

confidence: 99%